This drug, called SLU-PP-332, does not affect appetite but stimulates metabolic processes associated with physical activity.
As a result of its effect, metabolism and energy consumption are accelerated; This reminds us of what happens while exercising or fasting.
The main mechanism of action of the drug is aimed at affecting the ERR group of proteins that regulate basic metabolic pathways in energy-consuming organs. Typically these proteins are activated during physical activity.
In an experiment on obese mice, use of SLU-PP-332 led to a 10-fold reduction in gained fat and an overall weight loss of 12% of body weight.
The researchers plan to further optimize the drug and test it on more animals. Studies on humans are expected to begin in the future.
At this time, no serious side effects have been identified from the use of the drug.
Source: Ferra
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.
